Your session is about to expire
← Back to Search
N/A
Person-Centered Care for Improving Quality of Life
N/A
Waitlist Available
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Intended to receive radiation therapy to the breast/chest-wall and regional lymph nodes
Diagnosis of non-metastatic breast cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 weeks.
Awards & highlights
Study Summary
This trial is designed to study whether a person-centered model of care, which includes an additional educational session with a radiation therapist, can improve patient outcomes compared to the standard model of care.
Who is the study for?
This trial is for adults over 18 with non-metastatic breast cancer who speak English and can consent to treatment. They should be set to receive radiation therapy but haven't started any specific procedures or received previous radiation.Check my eligibility
What is being tested?
The study compares a person-centered model of care, which includes an extra education session, against the standard care during radiation therapy. Participants will answer quality of life questionnaires at different stages.See study design
What are the potential side effects?
Since this trial focuses on models of care and uses questionnaires without medical interventions, there are no direct side effects from drugs or treatments being studied.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am planning to undergo radiation therapy for my breast cancer.
Select...
My breast cancer has not spread to other parts of my body.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 weeks.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 weeks.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient Anxiety Levels
Secondary outcome measures
Patient-reported engagement level
Patient-reported experience
Patient-reported preparedness for radiation therapy
+1 moreSide effects data
From 2008 Phase 4 trial • 314 Patients • NCT007340975%
Headache
100%
80%
60%
40%
20%
0%
Study treatment Arm
Esomeprazole 40mg, Daily
Trial Design
2Treatment groups
Experimental Treatment
Group I: Standard Model-of-CareExperimental Treatment1 Intervention
Patients randomized to the standard model of care will be treated as per standard of care.
Group II: Person-Centered Model-of-CareExperimental Treatment1 Intervention
Patients randomized to the person-centered model-of-care will have a 30 minute education session with a radiation therapist in addition to the standard of care, radiation therapy procedures.
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
484,381 Total Patients Enrolled
53 Trials studying Breast Cancer
29,445 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am planning to undergo radiation therapy for my breast cancer.I have started preparations for radiation therapy.I have undergone radiation therapy before.My breast cancer has not spread to other parts of my body.
Research Study Groups:
This trial has the following groups:- Group 1: Person-Centered Model-of-Care
- Group 2: Standard Model-of-Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies within this clinical trial for participants?
"This clinical study, which was initially published on August 13th 2020 and last modified in October 6th 2022, is no longer recruiting patients. Nevertheless, there are 1640 other trials searching for volunteers at this moment."
Answered by AI
Share this study with friends
Copy Link
Messenger